Vitamin K-1 100 mcg

Vitamin K-1 100 mcg

Swanson Premium Brand4.7 (1,294 ratings)
Format:Tablet Quantity: 100 Tablet(s) · 100 servings
Goals
$10.99 $0.10 per serving

Product analysis

54 out of 100

Vitamin K-1 100 mcg offers an economical way to fill low vitamin K intake and support normal bone and mineral nutrition.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

Specific preparation details are incomplete, limiting a firm form comparison. The available detail does not establish an advantage over other vitamin K preparations.

Ingredient Transparency63

The vitamin K quantity is disclosed, making the serving amount clear. Specific preparation details are incomplete despite the K1 name.

Value For Money100

The vitamin K contribution is economical at the full serving cost. That value concerns nutrient supply rather than an advantage over another form.

Customer Satisfaction82

Customer ratings are favorable. A substantial number of ratings provides useful context for satisfaction.

Product Focus22

The narrow formula is most relevant to filling a vitamin K gap. Normal bone and mineral nutrition is better supported than wider claims for additional benefits.

Format
Tablet
Container
100 Tablet(s)
Per serving
$0.10
Customer rating
4.7 · 1,294 ratings
Report analysis

Goals

Everyday Health
Impact
High effect
B- Ingredient FitF PathwaysB EvidenceA+ Formulation Logic
Vitamin K · 100 mcg

Vitamin K supplies a nutrient involved in bone and mineral metabolism. Its 100 mcg serving can help fill a dietary gap, but nutrient availability does not establish extra benefit when intake is already adequate. The supplied context does not establish cardiovascular protection or superiority of this form.

How this product is rated for Everyday Health

Ingredient fit74

The main nutritional contributions come from Vitamin K. Amounts and unresolved nutrient declarations determine how much each contributes.
Goal fit
Vitamin K provide the main relevant nutrient contributions; other actives do not establish broader routine health benefits.
Dose adequacy
The nutrient amounts provide uneven contributions; smaller or unresolved amounts limit the saved findings.

Pathways17

The strongest supported area is bone and mineral metabolism. The other represented functions depend on the nutrients and amounts supplied.
Depth
The strongest contribution is in bone and mineral metabolism. This describes nutrient roles, not a proven improvement in health outcomes.
Breadth
The contribution remains limited to a single, partially represented nutrient function.

Evidence78

The supplied context supports nutritional roles, especially when intake is low. It does not establish extra health benefits above adequate intake.
Evidence strength
The relevant nutrients have supported nutritional roles; extra benefit in adults with adequate intake is not established.
Studied preparation
The saved findings accept the relevant preparations, without establishing superiority of their forms or delivery methods.

Formulation logic100

The relevant nutrients can contribute independently, and no matching conflict was found. Meeting the saved amount comparison does not establish a clinical benefit.
Partner coverage
The relevant nutrients can contribute independently or have their required partner present; this does not establish added benefit from combining them.
Conflicts
No matching conflict was found in the supplied checks; this is not a general safety conclusion.
Effective doses
The relevant ingredients meet the saved amount comparison, which does not prove an effective clinical dose.
Study evidence
Vitamin K Supportive 34 studies
Longevity
Impact
Limited evidence
F Ingredient FitF PathwaysF EvidenceF Formulation Logic
Vitamin K · 100 mcg
Study evidence
Vitamin K Supportive 27 studies
Heart Health
Impact
Limited evidence
F Ingredient FitF PathwaysF EvidenceF Formulation Logic
Vitamin K · 100 mcg
Study evidence
Vitamin K Mixed 62 studies

Ingredients

IngredientAmount per servingScore
Vitamin K-1
100 mcg 42
Adults 18–50
Report overview
Vitamin K · 100 mcg OverallScore42
F Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyA+ Value
Each serving provides 100 mcg of vitamin K1, a form used in normal blood clotting. The whole-product serving costs about $0.11.
How this ingredient is rated

Active Ingredient Quality & Bioavailability11

The identified vitamin K source is K1; no MK-7 source is resolved.
Vitamin K Form (MK-7 vs. MK-4 vs. K1)
Phytonadione is vitamin K1, which is involved in normal blood clotting.
MK-7 Isomer Disclosure
No MK-7 source is identified, so an MK-7 isomer cannot be assessed.

Dose, Safety & Label Transparency44

The saved information identifies 100 mcg of vitamin K1 per serving.
Vitamin K2 (MK-7) Dosage Efficacy
No MK-7 source is identified, so an MK-7 amount is not applicable to the resolved source.
Form and Subtype Transparency
Both the vitamin K1 form and its amount are identified.

Value100

At about $0.11 per whole-product serving, the price is relatively low.
Price per Effective MK-7 Serving
At about $0.11 per whole-product serving, the price is relatively low.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patients.
    Huang Y; Zhu X; Han L; Hu H · Scientific reports · 2025
    Cohort study7,857 participantsEveryday Health forVitamin K
  2. Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.
    Shea MK; Barger K; Booth SL; Matuszek G; Cushman M; Benjamin EJ; Kritchevsky SB; Weiner DE · The American journal of clinical nutrition · 2020
    Meta-analysis3,891 participants3 studies pooledEveryday Health Longevity forVitamin K
  3. The Effect of Topical Vitamin K1 on the Treatment of Cetuximab-Induced Skin Rashes in Metastatic Colorectal Cancer Patients.
    Roayaei M; Rezaei M; Najafizade N · Advanced biomedical research · 2024
    Randomized trial49 participantsEveryday Health forVitamin K
  4. Effect of vitamin K on improving post‑kidney transplant outcomes: a meta‑analysis.
    Sun Z; Zhu K; Liang G; Yan F; Chao S; Jia L; Niu Y · Experimental and therapeutic medicine · 2023
    Meta-analysis7 studies pooledEveryday Health forVitamin K
  5. Vitamin K1 intake is associated with lower risk for all-cause and cardiovascular disease mortality in community-dwelling older Australian women.
    Dupuy M; Radavelli-Bagatini S; Zhong L; Dalla Via J; Zhu K; Blekkenhorst LC; Bondonno NP; Linneberg A; Bellinge JW; Schultz C; Courtney W; Prince RL; Hodgson JM; Lewis JR; Sim M · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2024
    Cohort study1,436 participantsEveryday Health forVitamin K
  6. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
    Bellinge JW; Dalgaard F; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Sim M; Croft KD; Gislason G; Torp-Pedersen C; Tjønneland A; Overvad K; Hodgson JM; Schultz C; Bondonno NP · Journal of the American Heart Association · 2021
    Cohort study53,372 participantsHeart Health forVitamin K
  7. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
    Knapen MH; Braam LA; Drummen NE; Bekers O; Hoeks AP; Vermeer C · Thrombosis and haemostasis · 2016
    Randomized trial244 participantsHeart Health forVitamin K
  8. The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
    Bellinge JW; Francis RJ; Lee SC; Bondonno NP; Sim M; Lewis JR; Watts GF; Schultz CJ · The American journal of clinical nutrition · 2022
    Randomized trial149 participantsHeart Health forVitamin K
  9. Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
    Schultz CJ; Dalgaard F; Bellinge JW; Murray K; Sim M; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Gislason GH; Tjønneland A; Overvad K; Hodgson JM; Bondonno NP · Arteriosclerosis, thrombosis, and vascular biology · 2024
    Cohort study55,545 participantsHeart Health forVitamin K
  10. Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
    Palmer CR; Bellinge JW; Dalgaard F; Sim M; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Croft KD; Gislason G; Tjønneland A; Overvad K; Schultz C; Lewis JR; Hodgson JM; Bondonno NP · European journal of epidemiology · 2021
    Cohort study56,048 participantsHeart Health forVitamin K
  11. Topical Menaquinone‑7 (Vitamin K2, MK-7) as a Mitochondrial Bioenergetic Activator for Skin Anti-Aging: Mechanistic Evidence in Skin Cells and a Randomized Split-Face/Neck Study.
    Huang H; Wei R; Xu C; Liu C; Zhao S; Li Y; Wang M · ACS omega · 2026
    Randomized trial30 participantsLongevity forVitamin K
  12. Vitamin K status and cognitive function in healthy older adults.
    Presse N; Belleville S; Gaudreau P; Greenwood CE; Kergoat MJ; Morais JA; Payette H; Shatenstein B; Ferland G · Neurobiology of aging · 2014
    Cross-sectional study320 participantsLongevity forVitamin K
  13. High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam.
    Machado-Fragua MD; Hoogendijk EO; Struijk EA; Rodriguez-Artalejo F; Lopez-Garcia E; Beulens JW; van Ballegooijen AJ · European journal of nutrition · 2021
    Cohort study644 participantsLongevity forVitamin K
  14. Vitamin K Concentration and Cognitive Status in Elderly Patients on Anticoagulant Therapy: A Pilot Study.
    Alisi L; Cafolla C; Gentili A; Tartaglione S; Curini R; Cafolla A · Journal of aging research · 2022
    Cross-sectional study85 participantsLongevity forVitamin K